-
1.
公开(公告)号:US20080070932A1
公开(公告)日:2008-03-20
申请号:US10552306
申请日:2004-04-09
IPC分类号: A61K31/519 , A61P43/00 , C07D487/02 , C12N5/00
CPC分类号: C07D487/04
摘要: The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagofiists. thereof for preventing and/or treating numerous diseases, including C) Parkinson's disease. In one embodiment, the invention features a compound of formual (I).
摘要翻译: 本发明基于以下发现:式(I)化合物对A2a腺苷受体具有出人意料的高亲和力,并且可用作抗角膜炎药。 用于预防和/或治疗许多疾病,包括C)帕金森病。 在一个实施方案中,本发明的特征在于式(I)化合物。
-
2.Triazolotriazines and pyrazolotriazines and methods of making and using the same 失效
标题翻译: 三唑并三嗪和吡唑并三嗪及其制备和使用方法公开(公告)号:US07285550B2
公开(公告)日:2007-10-23
申请号:US10552303
申请日:2004-04-09
IPC分类号: C07D487/04 , C07D403/04 , C07D403/06 , C07D403/14 , A61K31/53 , A61P25/16
CPC分类号: C07D487/04
摘要: The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease. In one embodiment, the invention features a compound of formula I: (I)
摘要翻译: 本发明基于以下发现:式(I)化合物对Aβ2α腺苷受体具有意想不到的高亲和力,并且可用作其用于预防和/或治疗多种疾病的拮抗剂,包括帕金森病 疾病。 在一个实施方案中,本发明的特征在于式I的化合物:(I)
-
公开(公告)号:US08741837B2
公开(公告)日:2014-06-03
申请号:US13620573
申请日:2012-09-14
申请人: Deqiang Niu , Russell C. Petter , Juswinder Singh , Arthur F. Kluge , Lixin Qiao
发明人: Deqiang Niu , Russell C. Petter , Juswinder Singh , Arthur F. Kluge , Lixin Qiao
CPC分类号: C07K5/081 , A61K38/00 , C07K5/0202 , C07K5/06165 , C07K5/0804 , C07K5/0806 , C07K5/0808 , C07K5/0812 , C07K5/0815 , C07K5/0821 , C12N9/506 , C12N9/96 , C12N9/99
摘要: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
摘要翻译: 本发明提供化合物,其药学上可接受的组合物及其使用方法。
-
公开(公告)号:US08586600B2
公开(公告)日:2013-11-19
申请号:US13485037
申请日:2012-05-31
IPC分类号: C07D403/12 , C07D403/14 , C07D401/12 , C07D401/14 , A61K31/506 , A61P35/00 , A61P19/02
CPC分类号: C07D401/04 , A61K31/444 , A61K31/506 , A61K45/06 , C07D401/06 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
-
公开(公告)号:US08524760B2
公开(公告)日:2013-09-03
申请号:US13443847
申请日:2012-04-10
申请人: Deqiang Niu , Russell C. Petter , Lixin Qiao , Juswinder Singh
发明人: Deqiang Niu , Russell C. Petter , Lixin Qiao , Juswinder Singh
IPC分类号: A61K31/40 , C07D209/52
CPC分类号: C07K7/06 , A61K31/40 , A61K31/403 , A61K31/4439 , A61K31/4965 , A61K31/506 , A61K38/00 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/52 , C07D401/12 , C07D403/12 , C07K5/06165 , C07K5/0802 , C07K5/0804 , C07K5/0806 , C07K5/0808 , C07K5/081 , C07K5/0812 , C07K5/0817 , C07K5/0819 , C07K5/0821 , C07K5/0827 , C07K5/1016 , C12N9/506 , C12N9/99 , C12Y304/21098
摘要: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
-
公开(公告)号:US08445498B2
公开(公告)日:2013-05-21
申请号:US13018624
申请日:2011-02-01
IPC分类号: A01N43/54
CPC分类号: C07D239/48 , A61K31/505 , A61K31/506 , A61K31/5377 , A61K45/06 , C07B59/002 , C07B2200/05 , C07D239/47 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04 , C12N9/12 , C12Y207/10
摘要: The present invention provides 4,6-disubstituted pyrimidine compound useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
摘要翻译: 本发明提供可用作激酶抑制剂的4,6-二取代的嘧啶化合物,其药学上可接受的组合物及其使用方法。
-
公开(公告)号:US08293705B2
公开(公告)日:2012-10-23
申请号:US12497122
申请日:2009-07-02
申请人: Deqiang Niu , Russell C. Petter , Juswinder Singh , Arthur F. Kluge , Lixin Qiao
发明人: Deqiang Niu , Russell C. Petter , Juswinder Singh , Arthur F. Kluge , Lixin Qiao
IPC分类号: A61K38/00
CPC分类号: C07K5/081 , A61K38/00 , C07K5/0202 , C07K5/06165 , C07K5/0804 , C07K5/0806 , C07K5/0808 , C07K5/0812 , C07K5/0815 , C07K5/0821 , C12N9/506 , C12N9/96 , C12N9/99
摘要: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
-
公开(公告)号:US20120149687A1
公开(公告)日:2012-06-14
申请号:US13286061
申请日:2011-10-31
IPC分类号: A61K31/5377 , C07D239/34 , C07D413/12 , C07D403/12 , A61K31/506 , C07D295/155 , A61K31/5375 , A61K31/551 , C07D267/10 , A61K31/553 , C07D417/12 , A61K31/541 , A61P35/00 , C12N5/09 , C07D239/42
CPC分类号: A61K31/506 , A61K31/5377 , A61K31/541 , A61K31/551 , C07D239/34 , C07D239/42 , C07D239/47 , C07D239/48 , C07D403/14
摘要: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
-
公开(公告)号:US08017733B2
公开(公告)日:2011-09-13
申请号:US10892830
申请日:2004-07-16
申请人: KoChung Lin , R. Blake Pepinsky , Ling Ling Chen , Donna M. Hess , Edward Y. Lin , Russell C. Petter , Darren P. Baker
发明人: KoChung Lin , R. Blake Pepinsky , Ling Ling Chen , Donna M. Hess , Edward Y. Lin , Russell C. Petter , Darren P. Baker
CPC分类号: C08G65/329 , A61K47/60 , C08L2203/02
摘要: The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.
摘要翻译: 本发明涉及新型聚亚烷基二醇化合物及其使用方法。 特别地,包含新型聚乙二醇缀合物的化合物单独使用或与抗病毒剂组合用于治疗病毒感染,例如慢性丙型肝炎。
-
公开(公告)号:US20100069294A1
公开(公告)日:2010-03-18
申请号:US12497103
申请日:2009-07-02
申请人: Russell C. Petter , Juswinder Singh , Arthur F. Kluge , Deqiang Niu , Lixin Qiao , Shomir Ghosh
发明人: Russell C. Petter , Juswinder Singh , Arthur F. Kluge , Deqiang Niu , Lixin Qiao , Shomir Ghosh
CPC分类号: A61K47/48246 , A61K38/00 , A61K38/005 , A61K38/06 , A61K38/12 , A61K47/64 , C07D401/12 , C07K5/0202 , C07K5/06165 , C07K5/0804 , C07K5/0806 , C07K5/0808 , C07K5/081 , C07K5/0812 , C07K5/0815 , C07K5/0821 , C12N9/506 , C12N9/96 , C12Y304/00
摘要: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
-
-
-
-
-
-
-
-
-